on NANOBIOTIX (EPA:NANO)
NANOBIOTIX Prepares its Revolutionary Virtual Event
Biotech company Nanobiotix will announce its innovative nanotherapeutics platform at a virtual event on December 19, 2024. Focused on cancer treatments, the French company is committed to pushing the boundaries of traditional medicine with its Curadigm technology. The event, titled “Accelerating the Future of Nanotherapeutics,” will feature Laurent Levy and Matthieu Germain, who will unveil the potential of Curadigm, a technology aimed at improving intravenous drug delivery.
Experts including Margaret A. Liu and Jeffrey Bockman will participate in a panel discussion to discuss the opportunities offered by this platform. Nanobiotix, listed on Euronext and Nasdaq, continues to rely on innovation to optimize medical treatments, hoping to bring these advances to a broader audience.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NANOBIOTIX news